CovidResearchTrials by Shray Alag

CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)

none, this study is observationalWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (0)

Name (Synonyms) Correlation

Correlated MeSH Terms (1)

Name (Synonyms) Correlation
D018352 Coronavirus Infections NIH 0.04

Correlated HPO Terms (0)

Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials

1 Rehabilitation Needs After COVID-19 Hospital Treatment (REACT): an Observational Study

The onset of Coronavirus Disease 2019 (COVID-19) in the first months of 2020 had a huge impact on Italian population and Healthcare System, with more than 150.000 total confirmed cases1. SARS-CoV-2 is a highly contagious new virus, causing an influenza like illness and respiratory tract infection demonstrating fever (89%), cough (68%), fatigue (38%), sputum production (34%) and/or shortness of breath (19%). The aim of this observational study is to detect symptoms, disabilities, participation and the lived experience of the disease in individuals affected by COVID-19 two months after the hospital discharge.

NCT04438239 Covid-19 Other: none, this study is observational

Primary Outcomes

Description: Dyspnea will be measured with Medical Research Council (MRC), minimum value 0-maximum value 4, lower value= better outcome

Measure: number of participants with considerable dyspnea: Medical Research Council (MRC, 0-4, lower score better outcome)

Time: 2-months after hospital discharge

Description: Fatigue will be assessed with Fatigue Severity Scale (FSS), minimum value 9-maximum value 63, lower value=better outcome

Measure: number of participants with fatigue

Time: 2-months after hospital discharge

Description: anxiety will be assessed with Hospital Anxiety and Depression Scale (HADS), subscale 'Anxiety', minimum value 0-maximum value 24, lower score=better outcome, cut-off for clinically significant anxiety score>7

Measure: number of participants with anxiety

Time: 2-months after hospital discharge

Description: depression will be assessed with Hospital Anxiety and Depression Scale (HADS), subscale 'Depression', minimum value 0-maximum value 24, lower score=better outcome, cut-off for clinically significant depression score>7

Measure: number of participants with depression

Time: 2-months after hospital discharge

Secondary Outcomes

Description: independence or disability will be assessed with Barthel Index (BI), minimum score 0- maximum score 100, higher score=better outcome

Measure: level of independence in B-ADL

Time: 2-months after hospital discharge

Description: reintegration into normal social activities (e.g. recreation, movement in the community, and interaction in family or other relationships) will be assessed with Reintegration to Normal Living Index (RNLI), minimum score 0-maximum score 100, higher score=better outcome

Measure: level of participation in social

Time: 2-months after hospital discharge

Description: open ended questions will be recorded, transcribed verbatim and analyzed (two questions addressed to symptoms and limitations in activities that patients may have experienced during hospitalization or after discharge)

Measure: description of qualitative data about patients' experience

Time: 2-months after hospital discharge

No related HPO nodes (Using clinical trials)